Literature DB >> 21886394

Trisomy 9 in a Patient with Acute Myelogenous Leukaemia FAB Type M2: A Rare Occurrence.

R Chaubey, S Sazawal, R Dada, P Sharma, D Pathak, R Saxena.   

Abstract

Complete trisomy 9 is a rare cytogenetic abnormality in haematological malignancies. Here we present the case history of a patient with clinical diagnosis of acute myeloblastic leukaemia (FAB type M2) and having trisomy 9 with adverse outcome.

Entities:  

Keywords:  Acute myeloid leukemia; Karyotype; Trisomy 9

Year:  2010        PMID： 21886394      PMCID： PMC3002086          DOI： 10.1007/s12288-010-0035-1

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  10 in total

Review 1.  Molecular genetics and cytogenetics of myeloproliferative disorders.

Authors:  A J Bench; E P Nacheva; K M Champion; A R Green
Journal:  Baillieres Clin Haematol       Date:  1998-12

2.  Primary, single, autosomal trisomies associated with haematological disorders. United Kingdom Cancer Cytogenetics Group (UKCCG).

Authors: 
Journal:  Leuk Res       Date:  1992-09       Impact factor: 3.156

3.  Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.

Authors:  Francesc Solé; Elisa Luño; Carmen Sanzo; Blanca Espinet; Guillermo F Sanz; José Cervera; María José Calasanz; Juan Cruz Cigudosa; Fuensanta Millà; Josep Maria Ribera; Encarna Bureo; Maria Luisa Marquez; Eva Arranz; Lourdes Florensa
Journal:  Haematologica       Date:  2005-09       Impact factor: 9.941

Review 4.  Prenatal diagnosis of complete trisomy 9: a case report and review of the literature.

Authors:  Ounjai Kor-Anantakul; Chitkasaem Suwanrath; Samornmas Kanngurn; Sinitdhorn Rujirabanjerd; Thitima Suntharasaj; Sutham Pinjaroen
Journal:  Am J Perinatol       Date:  2006-02       Impact factor: 1.862

Review 5.  Pathological findings in the complete trisomy 9 syndrome: three case reports and review of the literature.

Authors:  Joan C Ferreres; Sílvia Planas; Elena A Martínez-Sáez; Teresa Vendrell; Vicente Peg; M Teresa Salcedo; Santiago Ramón Y Cajal; Núria Torán
Journal:  Pediatr Dev Pathol       Date:  2008 Jan-Feb

6.  Positive biochemical screening for trisomy 18: on the path of trisomy 9.

Authors:  Ana Póvoa; Carla Ramalho; Ana Torgal; Otília Brandão; Alexandra Matias; Maria J V Oliveira; Nuno Montenegro; Sérgio Castedo
Journal:  Prenat Diagn       Date:  2008-02       Impact factor: 3.050

7.  Prenatal diagnosis of nonmosaic trisomy 9 and related ultrasound findings at 11.7 weeks.

Authors:  M G Pinette; Y Pan; R Chard; S G Pinette; J Blackstone
Journal:  J Matern Fetal Med       Date:  1998 Jan-Feb

8.  Nonrandom aneuploidy of chromosomes 1, 5, 6, 7, 8, 9, 11, 12, and 21 induced by the benzene metabolites hydroquinone and benzenetriol.

Authors:  Luoping Zhang; Wei Yang; Alan E Hubbard; Martyn T Smith
Journal:  Environ Mol Mutagen       Date:  2005-05       Impact factor: 3.216

9.  Trisomy 9 in a patient with secondary acute myelogenous leukemia detected by fluorescent in situ hybridization.

Authors:  H F Mark; Y Gray; E Sotomayor; P Joseph
Journal:  Pathobiology       Date:  1999 Mar-Apr       Impact factor: 4.342

10.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

Authors:  D Grimwade; H Walker; F Oliver; K Wheatley; C Harrison; G Harrison; J Rees; I Hann; R Stevens; A Burnett; A Goldstone
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113
  10 in total
  1 in total

1.  Cannibalistic Hemophagocytosis in Acute Myeloid Leukemia with Trisomy 9.

Authors:  Somanath Padhi; Shruti Mishra; Gaurav Chhabra; Ashutosh Panigrahi
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-26       Impact factor: 0.900
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.